213 related articles for article (PubMed ID: 30629902)
1. Optimal Management of Neutropenic Fever in Patients With Cancer.
Zimmer AJ; Freifeld AG
J Oncol Pract; 2019 Jan; 15(1):19-24. PubMed ID: 30629902
[TBL] [Abstract][Full Text] [Related]
2. [Febrile neutropenia in cancer patients: management in the emergency room].
Rivera-Salgado D; Valverde-Muñoz K; Ávila-Agüero ML
Rev Chilena Infectol; 2018; 35(1):62-71. PubMed ID: 29652973
[TBL] [Abstract][Full Text] [Related]
3. Can mortality of cancer patients with fever and neutropenia be improved?
Thursky KA; Worth LJ
Curr Opin Infect Dis; 2015 Dec; 28(6):505-13. PubMed ID: 26374951
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
[TBL] [Abstract][Full Text] [Related]
5. Aztreonam for febrile neutropenia in patients with beta-lactam allergy.
McCullough BJ; Wiggins LE; Richards A; Klinker K; Hiemenz JW; Wingard JR
Transpl Infect Dis; 2014 Feb; 16(1):145-52. PubMed ID: 24119095
[TBL] [Abstract][Full Text] [Related]
6. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.
Braga CC; Taplitz RA; Flowers CR
J Oncol Pract; 2019 Jan; 15(1):25-26. PubMed ID: 30629901
[No Abstract] [Full Text] [Related]
8. Management of fever and neutropenia in paediatric cancer patients: room for improvement?
Haeusler GM; Sung L; Ammann RA; Phillips B
Curr Opin Infect Dis; 2015 Dec; 28(6):532-8. PubMed ID: 26381997
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of chemotherapy-induced febrile neutropenia in solid tumors].
Gálffy G
Magy Onkol; 2017 Sep; 61(3):261-266. PubMed ID: 28931099
[TBL] [Abstract][Full Text] [Related]
10. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.
Ko BS; Ahn S; Lee YS; Kim WY; Lim KS; Lee JL
Support Care Cancer; 2015 Sep; 23(9):2799-804. PubMed ID: 25663578
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
[TBL] [Abstract][Full Text] [Related]
12. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Observational Study of Antibiotic Therapy in Febrile Neutropenia Patients with Hematological Malignances from Multiple centers in Northeast China.
Zhai W; Zhang X; Wei J; Deng Q; Dong X; Zhang X; Zhang G; Ma Q; Zhang R; Su D; Feng S; Han M
Int J Infect Dis; 2015 Aug; 37():97-103. PubMed ID: 25931196
[TBL] [Abstract][Full Text] [Related]
14. A comparison of ED and direct admission care of cancer patients with febrile neutropenia.
Owolabi DK; Rowland R; King L; Miller R; Hegde GG; Shang J; Lister J; Venkat A
Am J Emerg Med; 2015 Jul; 33(7):966-9. PubMed ID: 25959844
[TBL] [Abstract][Full Text] [Related]
15. Management of fever and neutropenia in children with cancer.
Vedi A; Pennington V; O'Meara M; Stark K; Senner A; Hunstead P; Adnum K; Londall W; Maurice L; Wakefield C; Cohn RJ
Support Care Cancer; 2015 Jul; 23(7):2079-87. PubMed ID: 25533581
[TBL] [Abstract][Full Text] [Related]
16. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
Viscoli C; Bruzzi P; Glauser M
Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
[TBL] [Abstract][Full Text] [Related]
17. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
18. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
[TBL] [Abstract][Full Text] [Related]
19. Short-course antibiotics for chemotherapy-induced febrile neutropaenia: retrospective cohort study.
Seneviratne N; Yeomanson D; Phillips R
Arch Dis Child; 2020 Sep; 105(9):881-885. PubMed ID: 32184200
[TBL] [Abstract][Full Text] [Related]
20. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.
Koenig C; Schneider C; Morgan JE; Ammann RA; Sung L; Phillips B
Support Care Cancer; 2020 Mar; 28(3):1369-1383. PubMed ID: 31264188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
